Clinical Trials · NCT03845751

EvaluatioN of HIFU Hemiablation and Short Term AndrogeN Deprivation Therapy Combination to Enhance Prostate Cancer Control.

UnknownPhase 2Gonadorelin (Unclear)
Phase
Phase 2
Recruitment status
Unknown
Sponsor
Institut Mutualiste Montsouris
Enrollment
20
Start date
Jan 2023
Locations
1 site, France
Primary endpoint
Oncological outcome
View Gonadorelin compound reference